Expression and significance of chemokine-like factor 1 in the lungs of patients with severe acute respiratory syndrome

Y. Tan, W. Han, Y. Chen, D. Ma, N. Zhong (Guangzhou, Beijing, China)

Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Session: Determinants of acute lung injury and fibrosis
Session type: Thematic Poster Session
Number: 2445
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Tan, W. Han, Y. Chen, D. Ma, N. Zhong (Guangzhou, Beijing, China). Expression and significance of chemokine-like factor 1 in the lungs of patients with severe acute respiratory syndrome. Eur Respir J 2010; 36: Suppl. 54, 2445

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Regulation, cell-specific expression and metabolism of factor VII activating protease (FSAP) in lungs from patients with acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006

Angiopoietin like 4 as a clinical biomarker for acute respiratory distress syndrome
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019

Wnt5a and Wnt11 as acute respiratory distress syndrome biomarkers for severe acute respiratory syndrome coronavirus 2 patients
Source: Eur Respir J, 56 (5) 2001531; 10.1183/13993003.01531-2020
Year: 2020



Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome
Source: Eur Respir J 2009; 33: 543-550
Year: 2009



Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in acute respiratory distress syndrome (ARDS)
Source: Eur Respir J 2002; 20: Suppl. 38, 227s
Year: 2002

Pulmonary function in patients recovering from severe acute respiratory syndrome (SARS)
Source: Eur Respir J 2004; 24: Suppl. 48, 239s
Year: 2004

Pathogenesis of acute microvascular lung injury and the acute respiratory distress syndrome
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=22
Year: 2002

Variable tissue expression of transferrin receptors: relevance to acute respiratory distress syndrome
Source: Eur Respir J 2003; 22: 335-341
Year: 2003



The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance
Source: Eur Respir J 2014; 43: 276-285
Year: 2004



Pulmonary function and functional capacity in survivors of severe acute respiratory syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 239s
Year: 2004

The pathogenic role of macrophage migration inhibitory factor in acute respiratory distress syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 417s
Year: 2002

Duration of RT-PCR positivity in severe acute respiratory syndrome
Source: Eur Respir J 2005; 25: 12-14
Year: 2005



Elevated expression of TLR4 and HBD2 depict COPD patients with acute respiratory failure
Source: Eur Respir J 2007; 30: Suppl. 51, 132s
Year: 2007

Frequency and significance of vascular endothelial growth factor (VEGF) 936 C/T polymorphism in acute respiratory distress syndrome (ARDS)
Source: Eur Respir J 2002; 20: Suppl. 38, 227s
Year: 2002

Characterization of cytokine and chemokine profiles in the development of the severe acute respiratory syndrome(SARS)
Source: Eur Respir J 2004; 24: Suppl. 48, 239s
Year: 2004

Role of heat shock proteins in the lungs of acute lung injury
Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management
Year: 2006


Neuregulin-1 as a potentially novel biomarker in acute respiratory distress syndrome
Source: Eur Respir J 2013; 41: 259-261
Year: 2013


Acute increase in KL-6/MUC1 mucin as a potential trigger of disseminated intravascular coagulation in acute respiratory distress syndrome
Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management
Year: 2006


Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021


Mechanisms of acute lung injury
Source: Annual Congress 2005 - In vivo - approaches to lung injury
Year: 2005